Multiple Myeloma Market Anticipated to Grow at a CAGR of 6.81%

Ajouter une nouvelle offre d'emploi Autre

2026-09-15 09:30:24 -

The multiple myeloma market is essential to modern hematology-oncology care, providing an expanding portfolio of proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, CAR-T therapies, and bispecific antibodies for patients across all lines of therapy. The market is evolving through continued advancements in diagnostic technologies, targeted-therapy development, and immunotherapy...

0 Commentaires 0 Parts 480 Vue 0 Aperçu